Altria Group (MO) is back in focus after fourth quarter 2025 results, a goodwill impairment charge and fresh leadership moves, giving investors new information on earnings quality, capital returns and the smoke free product push.

Against this backdrop of impairment charges, buybacks and a planned CEO transition, Altria’s share price has a 30 day return of 8.58%, a 1 year total shareholder return of 26.19% and a 5 year total shareholder return of 113.81%. This points to momentum that has built up over several years rather than just the recent quarter.

If you are weighing Altria’s latest moves against other income ideas, it could be a good time to scan pharma stocks with solid dividends as another source of large dividend names.

With the shares near their average analyst target and management pointing to only modest adjusted EPS growth, the real question for you is whether Altria is still a value opportunity or if the market already reflects its future growth.

Most Popular Narrative: 2.5% Undervalued

Altria Group’s most followed narrative pegs fair value at about $63.83 per share versus the last close at $62.23, so the story assumes a small valuation gap rather than a deep discount.

The analysts have a consensus price target of $58.538 for Altria Group based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $73.0, and the most bearish reporting a price target of just $49.0.

Want to see what really sits behind that fair value line? The narrative leans heavily on steady earnings, firm margins and a future profit multiple that stands apart from today’s share price. Curious which assumptions have to hold together to keep that valuation intact?

Result: Fair Value of $63.83 (UNDERVALUED)

However, there is still a real risk that tighter tobacco regulation or a stronger push from illicit and synthetic nicotine products could pressure both revenue and margins.

Build Your Own Altria Group Narrative

If you are not fully convinced by this storyline or simply prefer to work from the raw figures yourself, you can build a fresh view in a few minutes, starting with Do it your way.

A great starting point for your Altria Group research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If you only stop with Altria, you could miss opportunities that fit your goals even better. Use the screener to widen your watchlist intelligently.

• Spot potential bargains early by checking these 876 undervalued stocks based on cash flows that align with your preferred mix of price and fundamentals.
• Tap into future tech growth themes by scanning these 24 AI penny stocks that are tied to real business models, not just hype.
• Strengthen your income watchlist by reviewing these 13 dividend stocks with yields > 3% that might suit a long term, cash flow focused portfolio.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.